JP2012529433A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012529433A5 JP2012529433A5 JP2012514221A JP2012514221A JP2012529433A5 JP 2012529433 A5 JP2012529433 A5 JP 2012529433A5 JP 2012514221 A JP2012514221 A JP 2012514221A JP 2012514221 A JP2012514221 A JP 2012514221A JP 2012529433 A5 JP2012529433 A5 JP 2012529433A5
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- alkyl
- aryl
- cyclic peptide
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 102000001189 Cyclic Peptides Human genes 0.000 claims description 17
- 108010069514 Cyclic Peptides Proteins 0.000 claims description 17
- 125000003118 aryl group Chemical group 0.000 claims description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- -1 —O-alkyl Chemical group 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 229940124530 sulfonamide Drugs 0.000 claims description 4
- 150000003456 sulfonamides Chemical class 0.000 claims description 4
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical group NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 4
- 150000001336 alkenes Chemical group 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 150000003141 primary amines Chemical group 0.000 claims 3
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 claims 2
- 102000004378 Melanocortin Receptors Human genes 0.000 claims 2
- 108090000950 Melanocortin Receptors Proteins 0.000 claims 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Chemical group CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims 2
- 150000001408 amides Chemical group 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Chemical group CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims 2
- 150000003335 secondary amines Chemical class 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims 1
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 1
- 150000003951 lactams Chemical class 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- MHHDMDLNVVCTAJ-UHFFFAOYSA-N Ic1ncc[nH]1 Chemical compound Ic1ncc[nH]1 MHHDMDLNVVCTAJ-UHFFFAOYSA-N 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N c1ccccc1 Chemical compound c1ccccc1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18492909P | 2009-06-08 | 2009-06-08 | |
| US61/184,929 | 2009-06-08 | ||
| PCT/US2010/037589 WO2010144344A2 (en) | 2009-06-08 | 2010-06-07 | Melanocortin receptor-specific peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012529433A JP2012529433A (ja) | 2012-11-22 |
| JP2012529433A5 true JP2012529433A5 (cg-RX-API-DMAC7.html) | 2013-07-25 |
| JP5805632B2 JP5805632B2 (ja) | 2015-11-04 |
Family
ID=43309425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012514221A Active JP5805632B2 (ja) | 2009-06-08 | 2010-06-07 | メラノコルチン受容体に特異的なペプチド |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US8846601B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2440227B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5805632B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101726893B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN105037502A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010259008C1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI1009644B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2761607C (cg-RX-API-DMAC7.html) |
| EA (1) | EA020959B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL216843A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011013117A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ596617A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010144344A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201200112B (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY32690A (es) | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Péptidos específicos para receptores de melanocortina |
| EP2440227B1 (en) | 2009-06-08 | 2017-10-18 | Palatin Technologies, Inc. | Melanocortin receptor-specific peptides |
| CA2781402C (en) | 2009-11-23 | 2017-03-21 | Palatin Technologies, Inc. | Melanocortin-1 receptor-specific cyclic peptides |
| CA2825098C (en) | 2011-01-27 | 2020-03-10 | Universite De Montreal | Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
| SMT202100734T1 (it) | 2011-12-29 | 2022-03-21 | Rhythm Pharmaceuticals Inc | Metodo di trattamento di disturbi associati al recettore di melanocortina 4 in portatori eterozigoti |
| US9284283B2 (en) | 2012-02-02 | 2016-03-15 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating IL-17 |
| EP2970388B1 (en) | 2013-03-15 | 2018-07-25 | Rhythm Pharmaceuticals, Inc. | Peptide compositions |
| JP6538025B2 (ja) * | 2013-03-15 | 2019-07-03 | リズム・ファーマシューティカルズ・インコーポレイテッド | 医薬組成物 |
| WO2015162287A1 (en) * | 2014-04-25 | 2015-10-29 | Phi Pharma Sa | Keratan sulfate specific transporter molecules |
| CN104436159A (zh) * | 2014-12-09 | 2015-03-25 | 天津医科大学眼科医院 | 一种新型滴眼液对治疗干眼的用途 |
| WO2016168388A2 (en) * | 2015-04-14 | 2016-10-20 | Palatin Technologies, Inc. | Therapies for obesity, diabetes and related indications |
| US10960046B2 (en) * | 2015-09-30 | 2021-03-30 | Rhythm Pharmaceuticals, Inc. | Method of treating melanocortin-4 receptor pathway-associated disorders |
| EP3538541A4 (en) * | 2016-11-09 | 2020-12-02 | Nanyang Technological University | PREPARATION AND USE OF GINSENOSIDES AND GINSENOSIDE-TYPE PEPTIDES |
| AU2019239300A1 (en) * | 2018-03-23 | 2020-11-19 | Palatin Technologies, Inc. | Melanocortin receptor-specific peptide formulations and methods for gastrointestinal tract-specific delivery |
| WO2019195756A1 (en) | 2018-04-06 | 2019-10-10 | Rhythm Pharmaceuticals, Inc. | Compositions for treating kidney disease |
| CN115515617A (zh) * | 2020-02-03 | 2022-12-23 | 帕拉丁科技公司 | 二胺连接的受体特异性环状肽 |
| CA3166448A1 (en) * | 2020-02-03 | 2021-08-12 | Wei Yang | Reverse amide-linked melanocortin receptor-specific cyclic peptides |
| CN114890958B (zh) * | 2022-02-23 | 2023-10-20 | 四川警察学院 | 双光子染料化合物、其制备方法及其应用 |
| CN115521356B (zh) * | 2022-08-17 | 2024-04-02 | 桂林医学院 | 一种具有美白功效的多肽及其应用 |
| CN119529031B (zh) * | 2024-11-27 | 2025-12-05 | 润辉生物技术（威海）有限公司 | 一种环肽衍生物及其制备方法与应用 |
Family Cites Families (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| AU7880991A (en) | 1990-05-10 | 1991-11-27 | Novo Nordisk A/S | A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
| US6100048A (en) | 1992-04-10 | 2000-08-08 | Oregon Health Sciences University | Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| US5977070A (en) | 1992-07-14 | 1999-11-02 | Piazza; Christin Teresa | Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| US6054556A (en) | 1995-04-10 | 2000-04-25 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Melanocortin receptor antagonists and agonists |
| US5731408A (en) | 1995-04-10 | 1998-03-24 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Peptides having potent antagonist and agonist bioactivities at melanocortin receptors |
| US7396814B2 (en) | 1995-06-07 | 2008-07-08 | Palatin Technologies, Inc. | Metallopeptide compositions for treatment of sexual dysfunction |
| EP0946595A2 (en) | 1996-12-17 | 1999-10-06 | Quadrant Holdings Cambridge Limited | Melanocortins |
| IL130532A0 (en) | 1996-12-20 | 2000-06-01 | Alza Corp | Gel composition and methods |
| US5908825A (en) | 1997-01-09 | 1999-06-01 | University Of Maryland At Baltimore | Dosage composition for nasal delivery and method of use of the same |
| US6350430B1 (en) | 1997-10-27 | 2002-02-26 | Lion Bioscience Science Ag | Melanocortin receptor ligands and methods of using same |
| US6193991B1 (en) | 1997-10-29 | 2001-02-27 | Atul J. Shukla | Biodegradable delivery systems of biologically active substances |
| GB9808229D0 (en) | 1998-04-17 | 1998-06-17 | Quadrant Holdings Cambridge | Melanocortin receptor ligands |
| SE9801571D0 (sv) | 1998-05-05 | 1998-05-05 | Wapharm Ab | Melanokortin-1-receptorselektiva föreningar |
| GB9816234D0 (en) | 1998-07-24 | 1998-09-23 | William Harvey Research Limite | Compounds for use in the treatment of inflammation |
| GB9827500D0 (en) | 1998-12-14 | 1999-02-10 | Wapharm Ab | Compounds for control of eating, growth and body weight |
| US6887846B2 (en) | 1999-03-24 | 2005-05-03 | Zengen, Inc. | Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
| WO2000058361A1 (en) | 1999-03-29 | 2000-10-05 | The Procter & Gamble Company | Melanocortin receptor ligands |
| US6579968B1 (en) * | 1999-06-29 | 2003-06-17 | Palatin Technologies, Inc. | Compositions and methods for treatment of sexual dysfunction |
| US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| US7235625B2 (en) | 1999-06-29 | 2007-06-26 | Palatin Technologies, Inc. | Multiple agent therapy for sexual dysfunction |
| US6699873B1 (en) | 1999-08-04 | 2004-03-02 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| US20030064921A1 (en) | 1999-10-27 | 2003-04-03 | The Regents Of The University Of California | Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| WO2001030808A1 (en) | 1999-10-27 | 2001-05-03 | The Regents Of The University Of California | Methods and compounds for modulating melanocortin receptor-ligand binding |
| US6693165B2 (en) | 2000-01-18 | 2004-02-17 | Merck & Co., Inc. | Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| US6600015B2 (en) | 2000-04-04 | 2003-07-29 | Hoffmann-La Roche Inc. | Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity |
| AU2001261363A1 (en) | 2000-05-09 | 2001-11-20 | The Regents Of The University Of California | Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| GB0012370D0 (en) | 2000-05-22 | 2000-07-12 | Quadrant Holdings Cambridge | Peptoids |
| RU2239642C1 (ru) * | 2000-08-30 | 2004-11-10 | Ф.Хоффманн-Ля Рош Аг | Селективные циклопептиды |
| CZ2003788A3 (cs) | 2000-09-27 | 2003-08-13 | The Procter & Gamble Company | Ligandy melanokortinového receptoru |
| IL159797A0 (en) * | 2001-07-11 | 2004-06-20 | Palatin Technologies Inc | Linear and cyclic melanocortin receptor-specific peptides |
| US7345144B2 (en) | 2001-07-11 | 2008-03-18 | Palatin Technologies, Inc. | Cyclic peptides for treatment of cachexia |
| US7342089B2 (en) * | 2001-07-11 | 2008-03-11 | Palatin Technologies, Inc. | Cyclic peptides for treatment for cachexia |
| WO2003006604A2 (en) | 2001-07-12 | 2003-01-23 | Merck & Co., Inc. | Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| FR2835528B1 (fr) | 2002-02-01 | 2004-03-12 | Inst Europ Biolog Cellulaire | Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique |
| US7034004B2 (en) | 2002-05-07 | 2006-04-25 | University Of Florida | Peptides and methods for the control of obesity |
| WO2004005324A2 (en) | 2002-07-09 | 2004-01-15 | Palatin Technologies, Inc. | Peptide composition for treatment of sexual dysfunction |
| US7135548B2 (en) | 2002-11-14 | 2006-11-14 | Zengen, Inc. | Modified α-MSH peptides and derivatives thereof |
| AU2003290886A1 (en) | 2002-11-14 | 2004-06-15 | Zengen, Inc. | Modified alpha-msh peptides and derivatives thereof |
| WO2004075783A2 (en) | 2003-02-26 | 2004-09-10 | Landry Donald W | A method for stabilizing blood pressure in hemodialysis subjects |
| MXPA05011830A (es) | 2003-05-09 | 2006-01-26 | Novo Nordisk As | Peptidos para uso en el tratamiento de la obesidad. |
| AU2004235872A1 (en) | 2003-05-09 | 2004-11-18 | Novo Nordisk A/S | Peptides for use in treating obesity |
| EP1644022A1 (en) | 2003-06-19 | 2006-04-12 | Eli Lilly And Company | Uses of melanocortin-3 receptor (mc3r) agonist peptides |
| CN1809372A (zh) * | 2003-06-19 | 2006-07-26 | 伊莱利利公司 | 黑皮质素受体4(mc4)激动剂及其用途 |
| JP2006527773A (ja) * | 2003-06-19 | 2006-12-07 | イーライ リリー アンド カンパニー | メラノコルチン受容体４（ｍｃ４）作用薬とその用途 |
| US7084111B2 (en) | 2003-06-23 | 2006-08-01 | University Of Florida Research Foundation, Inc. | Melanocortin receptor templates, peptides, and use thereof |
| BRPI0413676B8 (pt) | 2003-08-20 | 2021-05-25 | Lilly Co Eli | compostos derivados de oxazol e oxadiazol e composições farmacêuticas úteis para a liberação oral de composto de peptídeo semelhante a glucagon-1 (glp-1) ou de peptídeo agonista de receptores de melatonina tipo 4 (mc4) |
| EP1670815A2 (en) * | 2003-09-30 | 2006-06-21 | Novo Nordisk A/S | Melanocortin receptor agonists |
| JP5230941B2 (ja) | 2003-11-24 | 2013-07-10 | クリヌベール、ファーマスーティカルズ、リミテッド | Ｍｃ１ｒ変異対立遺伝子を有するヒトにおいてメラニン形成を誘導する方法 |
| WO2005060985A1 (en) | 2003-12-10 | 2005-07-07 | Merck & Co., Inc. | Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists |
| EP1732586A1 (en) | 2004-03-29 | 2006-12-20 | Eli Lilly And Company | Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continunous infusion |
| EP1789076B1 (en) | 2004-08-04 | 2016-01-20 | Clinuvel Pharmaceuticals Limited | Methods of inducing melanogenesis in a subject. |
| DE602005026970D1 (de) | 2004-10-25 | 2011-04-28 | Centocor Ortho Biotech Inc | Melanocortin-rezeptor-bindende mimetibodies, zusammensetzungen, verfahren und verwendungen |
| EP1809667A1 (en) | 2004-11-04 | 2007-07-25 | Novo Nordisk A/S | Peptides for use in the treatment of obesity |
| EP1809665A2 (en) | 2004-11-04 | 2007-07-25 | Novo Nordisk A/S | Mc4r selective peptides and their use in the treatment of obesity |
| CN101052650A (zh) | 2004-11-04 | 2007-10-10 | 诺和诺德公司 | 用于治疗肥胖的新颖的肽类 |
| EP1809666A2 (en) | 2004-11-04 | 2007-07-25 | Novo Nordisk A/S | Peptides for use in the treating obesity |
| WO2006097526A1 (en) | 2005-03-17 | 2006-09-21 | Novo Nordisk A/S | Compounds for use in the treatment of obesity |
| CN101528250A (zh) | 2005-07-08 | 2009-09-09 | 研究及应用科学协会股份有限公司 | 黑皮质素受体的配体 |
| PT3354273T (pt) * | 2005-07-08 | 2021-06-28 | Ipsen Pharma Sas | Ligandos do recetor de melanocortina |
| CN101222942A (zh) | 2005-07-18 | 2008-07-16 | 诺沃-诺迪斯克有限公司 | 用于治疗肥胖的肽 |
| WO2007027574A2 (en) | 2005-08-29 | 2007-03-08 | Palatin Technologies, Inc. | Cyclic peptide isolation by spray drying |
| US8114844B2 (en) * | 2006-03-30 | 2012-02-14 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptidomimetics |
| SI2865422T1 (sl) | 2006-08-31 | 2017-12-29 | Clinuvel Pharmaceuticals Limited | Alfa-MSH derivati za zdravljenje fotodermatoz |
| CN101177450A (zh) * | 2006-11-09 | 2008-05-14 | 武汉聚奇医药科技有限公司 | 引发男性阴茎勃起和提高女性性欲的短肽 |
| US20100016238A1 (en) | 2007-01-18 | 2010-01-21 | Novo Nordisk A/S | Peptides for Use in the Treatment of Obesity |
| US20100056433A1 (en) | 2007-01-18 | 2010-03-04 | Novo Nordisk A/S | Novel Peptides for Use in the Treatment of Obesity |
| US20100022446A1 (en) | 2007-01-18 | 2010-01-28 | Novo Nordisk A/S | Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity |
| EP2106405A2 (en) | 2007-01-18 | 2009-10-07 | Novo Nordisk A/S | Peptides for use in the treatment of obesity |
| CN101302246B (zh) * | 2007-05-09 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 黑色素皮质激素受体七肽类激动剂及其制备方法和用途 |
| TW200848424A (en) | 2007-06-15 | 2008-12-16 | Sod Conseils Rech Applic | Cyclic peptide melanocortin receptor ligands |
| RU2453328C2 (ru) | 2007-11-05 | 2012-06-20 | Ипсен Фарма С.А.С. | Применение меланокортинов для лечения чувствительности к инсулину |
| WO2009152079A1 (en) * | 2008-06-09 | 2009-12-17 | Palatin Technologies, Inc. | Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| UY32690A (es) | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Péptidos específicos para receptores de melanocortina |
| EP2440227B1 (en) * | 2009-06-08 | 2017-10-18 | Palatin Technologies, Inc. | Melanocortin receptor-specific peptides |
-
2010
- 2010-06-07 EP EP10786619.6A patent/EP2440227B1/en active Active
- 2010-06-07 MX MX2011013117A patent/MX2011013117A/es active IP Right Grant
- 2010-06-07 KR KR1020127000543A patent/KR101726893B1/ko active Active
- 2010-06-07 WO PCT/US2010/037589 patent/WO2010144344A2/en not_active Ceased
- 2010-06-07 CN CN201510295826.XA patent/CN105037502A/zh active Pending
- 2010-06-07 CA CA2761607A patent/CA2761607C/en active Active
- 2010-06-07 BR BRPI1009644-2A patent/BRPI1009644B1/pt active IP Right Grant
- 2010-06-07 NZ NZ596617A patent/NZ596617A/en unknown
- 2010-06-07 CN CN201080024349.9A patent/CN102458436B/zh active Active
- 2010-06-07 AU AU2010259008A patent/AU2010259008C1/en not_active Ceased
- 2010-06-07 JP JP2012514221A patent/JP5805632B2/ja active Active
- 2010-06-07 EA EA201190338A patent/EA020959B1/ru not_active IP Right Cessation
-
2011
- 2011-12-06 US US13/311,824 patent/US8846601B2/en active Active
- 2011-12-08 IL IL216843A patent/IL216843A/en active IP Right Grant
-
2012
- 2012-01-07 ZA ZA2012/00112A patent/ZA201200112B/en unknown
-
2014
- 2014-07-11 US US14/328,995 patent/US9458201B2/en active Active
-
2016
- 2016-07-20 US US15/214,845 patent/US10179804B2/en active Active
-
2019
- 2019-01-11 US US16/245,735 patent/US10632171B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012529433A5 (cg-RX-API-DMAC7.html) | ||
| JP2013511553A5 (cg-RX-API-DMAC7.html) | ||
| JP2013511554A5 (cg-RX-API-DMAC7.html) | ||
| JP2016523241A5 (cg-RX-API-DMAC7.html) | ||
| RU2014137107A (ru) | Пептидомиметические макроциклы | |
| CN102711802B (zh) | 肽glp‑2激动剂 | |
| JP2020502051A5 (cg-RX-API-DMAC7.html) | ||
| EP0804463A1 (de) | Neurokinin (tachykinin)-antagonisten | |
| RU2014148530A (ru) | Производные дипептида лизин-глутаминовая кислота | |
| JP2013533864A5 (cg-RX-API-DMAC7.html) | ||
| MY161450A (en) | Double-acylated glp-1 derivatives | |
| JP2009527499A5 (cg-RX-API-DMAC7.html) | ||
| RU2010123466A (ru) | Пептидное производное - миметик эритропоэтина и его фармацевтические соли, их получение и применение | |
| KR20140014081A (ko) | 아밀로이드 피브릴 형성과 관련된 증상 치료용 디펩티드 유사체 | |
| US20230183291A1 (en) | Anti-infective bicyclic peptide ligands | |
| RU2006144279A (ru) | Пептидные соединения | |
| CN105658670A (zh) | 肽-低聚尿素嵌合化合物及其使用方法 | |
| JP2018531284A6 (ja) | 環状ポリペプチド、それらを得る方法、及びその治療的使用 | |
| JP2018531284A (ja) | 環状ポリペプチド、それらを得る方法、及びその治療的使用 | |
| AU744425B2 (en) | 20(s) camptothecin glycoconjugates | |
| CA3206846A1 (en) | Anti-infective bicyclic peptide ligands | |
| JP2020189806A (ja) | 複合体 | |
| RU2007118385A (ru) | Контрастные агенты для направлений доставки во внеклеточный матрикс | |
| CN106279357A (zh) | 双[(乙酰-Lys(AA)-OBzl)吲哚]乙烷,其制备,活性和应用 | |
| JP2016536372A5 (cg-RX-API-DMAC7.html) |